Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 14.90B | € 14.73B | € 13.60B | € 11.87B | € 15.79B |
Total Assets | € 157.44B | € 153.95B | € 154.10B | € 155.06B | € 156.86B |
Total Debt | € 75.58B | € 67.18B | € 69.52B | € 66.80B | € 68.82B |
Net Debt | € 60.69B | € 52.45B | € 55.92B | € 54.92B | € 53.03B |
Total Liabilities | € 99.70B | € 96.98B | € 96.05B | € 97.25B | € 97.28B |
Stockholders Equity | € 55.45B | € 54.69B | € 55.89B | € 55.80B | € 58.36B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |